Patent · US Active

Method for resolving omeprazole salts

US8034948B2 · kind B2 · utility

2Cited by
0References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 29, 2008
Grant dateOct 11, 2011
Priority date
Expiry dateJun 5, 2030

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P1/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to the resolution by preferential crystallization of potassium salts of racemic omeprazole which is a solvate of ethanol and/or of ethylene glycol, which consists in converting the omeprazole to the potassium salt in the form of a solvate or of a mixture of these solvates in the presence of an excess of inorganic base which is a source of potassium, the said potassium salts existing in the form of conglomerates, and in then resolving the said conglomerates, independently or simultaneously, by preferential crystallization in order to separate the two (S) and (R) enantiomers of these potassium salts of omeprazole.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.